Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer

Complementary Therapies in Medicine

Volumn 20, Issue 5, 2012, Pages 283-290

  Saquib, Juliann ^a   Parker, Barbara A ^a   Natarajan, Loki ^a   Madlensky, Lisa ^a   Saquib, Nazmus ^a   Patterson, Ruth E ^a   Newman, Vicky A ^a   Pierce, John P ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alternative cancer treatment; Breast cancer; Complementary and alternative medicine; Dietary supplements; Long term prognosis

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; HOMEOPATHIC AGENT; MINERAL; MULTIVITAMIN;

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHIROPRACTIC; CONTROLLED STUDY; CRYSTAL THERAPY; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; FRUIT; GUIDED IMAGERY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOMEOPATHY; HUMAN; LOW FAT DIET; MAGNETOTHERAPY; MAJOR CLINICAL STUDY; MASSAGE; MEDITATION; MULTICENTER STUDY; MUSIC THERAPY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REIKI; RELAXATION TRAINING; RISK ASSESSMENT; SECONDARY ANALYSIS; SPIRITUAL HEALING; TAI CHI; UNITED STATES; VEGETABLE; WOMEN'S HEALTH; YOGA;

ADULT; AGED; BREAST NEOPLASMS; CAUSE OF DEATH; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; SURVIVORS; UNITED STATES;

EID: 84864774171     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2012.04.002     Document Type: Article

References (44)

1. Ries L, Eisner M. SEER Survival Monograph: Cancer Survival Among Adults: Cancer SEER Program, 1988-2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute;2007. 07-6215.
2. Punglia R.S., Morrow M., Winer E.P., Harris J.R. Local therapy and survival in breast cancer. New England Journal of Medicine 2007, 356:2399-2405.
3. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. New England Journal of Medicine 1995, 333:1444-1455.
4. Bickell N.A., Weidmann J., Fei K., Lin J.J., Leventhal H. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. Journal of Clinical Oncology 2009, 27:5160-5167.
5. Polacek G.N., Ramos M.C., Ferrer R.L. Breast cancer disparities and decision-making among U.S. women. Patient Education and Counseling 2007, 65:158-165.
6. Bickell N.A., LePar F., Wang J.J., Leventhal H. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. Journal of Clinical Oncology 2007, 25:2516-2521.
7. Fagerlin A., Lakhani I., Lantz P.M., Janz N.K., Morrow M., Schwartz K., et al. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Education and Counseling 2006, 64:303-312.
8. Katz S.J., Lantz P.M., Janz N.K., Fagerlin A., Schwartz K., Liu L., et al. Patient involvement in surgery treatment decisions for breast cancer. Journal of Clinical Oncology 2005, 23:5526-5533.
9. Rees L., Weil A. Integrated medicine. British Medical Journal 2001, 322:119-120.
10. Burstein H.J., Gelber S., Guadagnoli E., Weeks J.C. Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine 1999, 340:1733-1739.
11. Kimby C.K., Launso L., Henningsen I., Langgaard H. Choice of unconventional treatment by patients with cancer. Journal of Alternative and Complementary Medicine 2003, 9:549-561.
12. Velicer C.M., Ulrich C.M. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. Journal of Clinical Oncology 2008, 26:665-673.
13. NCCAM CAM basics what is complementary and alternative medicine? 2000, U.S. Department of Health and Human Services, National Institutes of Health, National Center for Complementary and Alternative Medicine, Bethesda.
14. Richardson M.A., Sanders T., Palmer J.L., Greisinger A., Singletary S.E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology 2000, 18:2505-2514.
15. Cassileth B.R., Deng G. Complementary and alternative therapies for cancer. Oncologist 2004, 9:80-89.
16. Bardia A., Barton D.L., Prokop L.J., Bauer B.A., Moynihan T.J. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. Journal of Clinical Oncology 2006, 24:5457-5464.
17. Bardia A., Wahner-Roedler D.L., Erwin P.L., Sood A. Search strategies for retrieving complementary and alternative medicine clinical trials in oncology. Integrative Cancer Therapies 2006, 5:202-205.
18. Gerber B., Scholz C., Reimer T., Briese V., Janni W. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Research and Treatment 2006, 95:199-209.
19. Henderson J.W., Donatelle R.J. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Alternative Therapies in Health and Medicine 2004, 10:52-57.
20. Nahleh Z., Tabbara I.A. Complementary and alternative medicine in breast cancer patients. Palliat Support Care 2003, 1:267-273.
21. Shen J., Andersen R., Albert P.S., Wenger N., Glaspy J., Cole M., et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Alternative Medicine 2002, 2:8.
22. Tagliaferri M., Cohen I., Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Seminars in Oncology 2001, 28:121-134.
23. Ernst E., Schmidt K., Baum M. Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomized clinical trials and a critique of current terminology. The Breast Journal 2006, 12:526-530.
24. Chang E.Y., Glissmeyer M., Tonnes S., Hudson T., Johnson N. Outcomes of breast cancer in patients who use alternative therapies as primary treatment. American Journal of Surgery 2006, 192:471-473.
25. Pierce J.P., Natarajan L., Caan B.J., Parker B.A., Greenberg E.R., Flatt S.W., et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. Journal of American Medical Association 2007, 298:289-298.
26. Pierce J.P., Faerber S., Wright F.A., Rock C.L., Newman V., Flatt S.W., et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Controlled Clinical Trials 2002, 23:728-756.
27. Newman V., Rock C.L., Faerber S., Flatt S.W., Wright F.A., Pierce J.P. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. Journal of the American Dietetic Association 1998, 98:285-292.
28. Rock C.L., Newman V., Flatt S.W., Faerber S., Wright F.A., Pierce J.P. Nutrient intakes from foods and dietary supplements in women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. Nutrition and Cancer 1997, 29:133-139.
29. Waldron I., Lye D. Family roles and smoking. American Journal of Preventive Medicine 1989, 5:136-141.
30. Lof M., Hannestad U., Forsum E. Comparison of commonly used procedures, including the doubly-labelled water technique, in the estimation of total energy expenditure of women with special reference to the significance of body fatness. British Journal of Nutrition 2003, 90:961-968.
31. Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., Colditz G.A. Physical activity and survival after breast cancer diagnosis. Journal of American Medical Association 2005, 293:2479-2486.
32. Yood M.U., Owusu C., Buist D.S., Geiger A.M., Field T.S., Thwin S.S., et al. Mortality impact of less-than-standard therapy in older breast cancer patients. Journal of the American College of Surgeons 2008, 206:66-75.
33. Srokowski T.P., Fang S., Duan Z., Buchholz T.A., Hortobagyi G.N., Goodwin J.S., et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 2008, 113:22-29.
34. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Journal of the National Cancer Institute 2005, 97:1407-1427.
35. Ernst E., Pittler M.H., Wider B., Boddy K. Complementary/alternative medicine for supportive cancer care: development of the evidence-base. Supportive Care in Cancer 2007, 15:565-568.
36. Cassileth B.R., Gubili J. Integrative oncology: complementary therapies in cancer care. Supportive care in cancer therapy 2008, 269-277. Humana Press, Totowa, NJ. D.S. Ettinger (Ed.).
37. Post-White J., Kinney M.E., Savik K., Gau J.B., Wilcox C., Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integrative Cancer Therapies 2003, 2:332-344.
38. Walker L.G., Walker M.B., Ogston K., et al. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. British Journal of Cancer 1999, 80:262-268.
39. Kolcaba K., Fox C. The effects of guided imagery on comfort of women with early stage breast cancer undergoing radiation therapy. Oncology Nursing Forum 1999, 26:67-72.
40. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosomatic Medicine 2003, 65:571-581.
41. Fink B.N., Gaudet M.M., Britton J.A., Abrahamson P.E., Teitelbaum S.L., Jacobson J., et al. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Research and Treatment 2006, 98:199-208.
42. Holmes M.D., Stampfer M.J., Colditz G.A., Rosner B., Hunter D.J., Willett W.C. Dietary factors and the survival of women with breast carcinoma. Cancer 1999, 86:826-835.
43. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Research 1998, 58:3833-3838.
44. Robotin M.C., Penman A.G. Integrating complementary therapies into mainstream cancer care: which way forward?. Medical Journal of Australia 2006, 185:377-379.